GKOS vs TECH · rev $383.5M vs P/E 65, rev $1.22B
Glaukos Corp (GKOS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Glaukos Corp (GKOS) is a medical devices company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported GKOS revenue for 2024-12-31 was $383.5M. Net income was -$146.4M. Revenue was up 21.9% from 2023-12-31 to 2024-12-31. GKOS currently screens at market cap $7.63B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
GKOS currently screens at market cap $7.63B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the GKOS and TECH stock pages for the full models.
Not investment advice.